Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Licensing pipeline
GLP-1/CIP
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB662)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GLP-1/GIP/GCG
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB661)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
GLP-1
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB660)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
IL-4R
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB659)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Trop2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB658)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
ROR1
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB657)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
LIV-1
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB656)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CD46
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB650)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- FR
Licensing pipeline
HER2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB649)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Pan-specific T cell antigen
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB648)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States
Licensing pipeline
APP
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB643)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
HBV preS1
—
- Therapy
- Gastroenterology & Hepatology
- Status
- Candidate licensing (UB642)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
PCSK9/LPA
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB641)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
PCSK9/AGT
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB640)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
APOC3
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB639)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
LPA
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB638)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China, United States
Licensing pipeline
MC2R; MC4R
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB631)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States, China
Licensing pipeline
GLP-1
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB609)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States
Licensing pipeline
CEA-CAM/4-1BB/CD3
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB568)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CEA/CDH17
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB567)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
Her2/Her2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB566)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
EGFR/cMet
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB565)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
ALK
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB564)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
PD1-IL2
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB563)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
DPP-1/CTSK
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB562)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
TYK2/JAK1
—
- Therapy
- Immunology & Inflammation
- Status
- Candidate licensing (UB561)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
ActRIIA
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB560)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
RdRp Inhibitor
—
- Therapy
- Others > Respiratory
- Status
- Candidate licensing (UB523)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
immune modulator
—
- Therapy
- Gastroenterology & Hepatology
- Status
- Candidate licensing (UB522)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- Unknown
Licensing pipeline
P2Y12R
—
- Therapy
- Cardiovascular
- Status
- Candidate licensing (UB521)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States
Licensing pipeline
THR-β
—
- Therapy
- Metabolic & Endocrinology
- Status
- Candidate licensing (UB520)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
voltage-gated sodium channel
—
- Therapy
- Others > Anesthesiology
- Status
- Candidate licensing (UB519)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
voltage-gated sodium channel
—
- Therapy
- Others > Anesthesiology
- Status
- Candidate licensing (UB518)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
IDH1 mutation
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB509)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB499
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB499)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB498
—
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Candidate licensing (UB498)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB497
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB497)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB496
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB496)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB495
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB495)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
CD7
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB494)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- United States, China
Licensing pipeline
UB493
—
- Therapy
- Oncology
- Status
- Candidate licensing (UB493)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB439
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB439)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB438
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB438)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB437
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB437)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB436
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB436)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB435
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB435)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China, United States
Licensing pipeline
UB434
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB434)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China
Licensing pipeline
UB433
—
- Therapy
- Neurology
- Status
- Candidate licensing (UB433)· Preclinical
- Registration
- Licensing / co-development (by target & stage)
- Markets
- China, United States